Condensed Balance Sheets - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Current assets
Cash and cash equivalents	$ 157,540	$ 122,162
Marketable securities, short-term	42,654	72,075
Prepaid expenses and other current assets	2,366	4,424
Total current assets	202,560	198,661
Marketable securities, long-term		31,619
Property and equipment, net	142	36
Deferred offering costs	337
Right-of-use asset	133
Other assets	92	14
Total assets	203,264	230,330
Current liabilities
Accounts payable	2,084	1,088
Accrued expenses and other current liabilities	4,396	4,059
Operating lease liability, current portion	133
Total current liabilities	6,613	5,147
Total liabilities	6,613	5,147
Commitments and contingencies (Note 9)
Stockholders' equity
Preferred stock, $0.0001 par value; 10,000,000 shares authorized and no shares issued and outstanding as of September 30, 2022 and December 31, 2021
Common stock, $0.0001 par value; 300,000,000 shares authorized and 40,503,124 and 40,473,270 shares issued and outstanding as of September 30, 2022 and December 31, 2021, respectively	4	4
Additional paid-in capital	355,173	352,981
Accumulated deficit	(157,561)	(127,571)
Accumulated other comprehensive loss	(965)	(231)
Total stockholders' equity	196,651	225,183
Total liabilities and stockholders' equity	$ 203,264	$ 230,330